title: Vasopeptidase inhibitors--concepts and evidence.
authors.forename: F
authors.initials: F
authors.lastname: Ruschitzka
authors.forename: R
authors.initials: R
authors.lastname: Corti
authors.forename: T
authors.initials: T
authors.lastname: Quaschning
authors.forename: M
authors.initials: M
authors.lastname: Hermann
authors.forename: T F
authors.initials: TF
authors.lastname: Lüscher
mesh_terms: D000799:Angioedema / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D045283:Natriuretic Agents / Q000502:physiology; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000378:metabolism; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D045283:Natriuretic Agents; D011480:Protease Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D015260:Neprilysin